Environmental, Social And Governance Report

Overview

The report is Qyuns Therapeutics' first ESG report covering the company and its subsidiaries for 2023. It highlights Board-led ESG governance and a materiality assessment identifying 19 issues. Environmental disclosures include 335.80 Tons of CO2e of Scope 1 emissions, 7,278.40 Tons of CO2e of Scope 2 emissions, 10,822,657.06 kWh of total energy consumption, and 76,017 cubic meters of water consumption.

Document

Report type: Sustainability Report
Class: Dedicated
Scope: Full report
Fiscal year: 2023
Period: 1 January 2023 – 31 December 2023
Language: English
Pages
File size

Standards

GRI
SASB
TCFD
ISSB
ESRS
Integrated Reporting Framework
GHG Protocol
EU Taxonomy
CDP
Other

Ratings

GRI level

Materiality

Assessment
Basis
Matrix

Assurance

Statement included

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services